MedPath

Evaluating the Efficacy of a Novel Oral Supplement in Tackling Malnutrition in the Elderly

Not Applicable
Conditions
Malnutrition
Muscle Health
Interventions
Dietary Supplement: ONS
Registration Number
NCT02683720
Lead Sponsor
Wageningen University
Brief Summary

ProMO aims to investigate the effectiveness of a newly developed ONS in increasing body weight, muscle mass and function in malnourished elderly compared to standard care.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
82
Inclusion Criteria
  • age 65+
  • at risk of malnutrition/ malnourished
Exclusion Criteria
  • • Mental status that is incompatible with the proper conduct of the study

    • Illness of such severity that life expectancy is considered to be less than 12 months
    • Use of diabetes medication (e.g. insulin, methformin)
    • Use of an oral nutritional supplement in the previous three months
    • Participating in any regular exercise training program (≥2h/w)
    • Renal insufficiency (eGFR <30 mL/min/1.73 m2)
    • Unstable organ failure or organ failure necessitating a special diet
    • Chronic corticosteroids use
    • Recent (previous 2 months) use of antibiotics
    • Recent (previous 3 months) change in habitual medication use (e.g statins and thyroxin)
    • Recent blood donation (<1 month prior to Day 01 of the study)
    • Not willing or afraid to give blood during the study
    • Allergic or sensitive for milk proteins
    • Reported vegan or macrobiotic life-style
    • Drug and/or alcohol abuse (current consumption of more than 21 alcoholic drinks per week)
    • Individual unable to give informed consent
    • Current participation in other research from the Division of Human Nutrition
    • Not having a general practitioner
    • Personnel of Wageningen University, department of Human Nutrition, their partner and their first and second degree relatives

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ONS2ONSusual care
ONS1ONSnew product
Primary Outcome Measures
NameTimeMethod
lean body mass12 weeks
Secondary Outcome Measures
NameTimeMethod
body weight12 weeks

Trial Locations

Locations (1)

Wageningen University

🇳🇱

Wageningen, Netherlands

© Copyright 2025. All Rights Reserved by MedPath